EntreMed(美國)

EntreMed

EntreMed www.entremed.comEntreMed,Inc.是一家致力于開發(fā)ENMD-2076的臨床階段制藥公司。ENMD-2076是用于治療癌癥的選擇性血管生成激酶抑制劑。ENMD-2076目前正在進行一項多中心二期卵巢癌研究，并且已經(jīng)完成了多個有關(guān)實體腫瘤、多發(fā)性骨髓瘤和白血病的一期研究EntreMed,Inc.9640MedicalCenterDriveRockville, MD20850Phone:(240)864-2600Fax:(301)315-2437英創(chuàng)遠達(北京)生物醫(yī)藥科技有限公司EntreMed(Beijing),Inc.HanhaiCulturePlazaSuite716Building28-1XiangJunBeiLiChaoyangDistrictBeijing100025P.R.ChinaInvestorRelations(240)864-2643investorrelations@entremed.comEntreMed,Inc.isaclinical-stagepharmaceuticalcompanyemployingadrugdevelopmentstrategyprimarilyintheUnitedStatesandChinatodeveloptargetedtherapeuticsfortheglobalmarket.Itsleadcompound,ENMD-2076,aselectiveangiogenickinaseinhibitor,hascompletedseveralPhase1studiesinsolidtumors,multiplemyeloma,andleukemia,